Skip to main content
. Author manuscript; available in PMC: 2011 Feb 16.
Published in final edited form as: Med Sci Sports Exerc. 2008 Feb;40(2):223–233. doi: 10.1249/mss.0b013e31815bbba9

TABLE 5.

Hormone concentrations by change in V̇O2max from baseline to 12 months.

Baseline Geometric Mean (95% CI) 3-month Geometric Mean (95% CI) % Δ P* P** 12-month Geometric Mean (95% CI) % Δ P* P**
DHT (ng·dL−1)
 Control 459 (406, 518) 467 (413, 529) +1.7 Ref. N/A 445 (393, 503) −3.1 Ref. N/A
 Decrease or < 5% increase 347 (282, 426) 369 (296, 461) +6.3 0.52 Ref. 347 (289, 416) 0.0 0.51 Ref.
 5–15% increase 449 (358, 563) 504 (428, 593) +12.2 0.33 0.59 491 (409, 591) +9.4 0.33 0.49
 > 15% increase 372 (303, 456) 454 (371, 554) +22.0 0.002 0.05 466 (384, 564) +25.7 0.001 0.003
P *** = 0.006 P *** = 0.05 P *** = 0.001 P *** = 0.003
SHBG (nM)
 Controla 30.0 (27.0, 33.4) 31.7 (28.6, 35.1) +5.7 Ref. N/A 31.2 (28.2, 34.7) +4.0 Ref. N/A
 Decrease or < 5% increaseb 24.1 (19.4, 29.9) 27.7 (22.6, 33.9) +14.9 0.17 Ref. 26.4 (22.2, 31.5) +9.5 0.27 Ref.
 5–15% increasec 32.4 (27.6, 38.1) 35.0 (30.4, 40.3) +8.0 0.56 0.29 35.3 (30.0, 41.6) +9.0 0.49 0.94
 > 15% increased 24.8 (21.7, 28.4) 29.8 (26.2, 34.0) +20.2 0.002 0.47 28.9 (25.2, 33.3) +16.5 0.02 0.30
P *** = 0.01 P *** = 0.43 P *** = 0.04 P *** = 0.28
*

P value testing the difference between change in V̇O2max tertiles and controls from baseline to 12 months vs control group.

**

P value testing the difference between change in V̇O2max tertiles and the decrease or < 5% increase group, excluding controls.

***

P value testing a trend across change in V̇O2max tertiles for change from baseline to 12 months.

a

N = 51.

b

N = 15.

c

N = 15.

HHS Vulnerability Disclosure